T1	Participants 111 128	randomised trials
T2	Participants 276 523	childhood acute lymphoblastic leukaemia (UKALL X) randomised patients aged 0-14 years inclusive with an initial white blood count of less than 100 x 10(9)/l to receive an early intensification block, a late intensification block, both, or neither.
T3	Participants 540 578	UKALL XI, for children aged 1-14 years
T4	Participants 689 790	all patients were also randomised between late intensification alone and both early plus late blocks.
